By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Waltham, Massachusetts) 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Tesaro (TSRO) Release: 2016 ESMO Annual Meeting Investor Briefing 9/22/2016 8:45:29 AM
Why Gilead (GILD) Should Think About Wooing Massachusetts' Tesaro (TSRO) 9/14/2016 6:42:08 AM
Tesaro (TSRO) Receives FDA Fast Track Designation For Niraparib And Initiates Rolling NDA Submission 9/12/2016 10:40:52 AM
Tesaro (TSRO) Announces Six Data Presentations At The 2016 European Society For Medical Oncology (ESMO) Annual Meeting 9/6/2016 2:35:29 PM
Tesaro (TSRO) Announces Participation At Four Investor Conferences 8/25/2016 8:29:22 AM
Tesaro (TSRO) To Announce Second-Quarter 2016 Financial Results On August 4, 2016 7/22/2016 8:44:09 AM
ENGOT And Tesaro (TSRO) Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial 7/11/2016 8:29:48 AM
Tesaro (TSRO) Announces Closing Of Public Offering Of Common Stock And Exercise Of Option By Underwriters 7/8/2016 9:45:15 AM
Tesaro (TSRO) Stock Soars as Acquisition Rumors Swirl After Excellent Phase III Results 7/1/2016 8:16:29 AM
Myriad Genetics (MYGN)’s myChoice HRD Test Successfully Identifies Patients That Meet Primary Endpoint In Tesaro (TSRO)’s Pivotal Phase 3 Ovarian Cancer Study With Niraparib 6/29/2016 6:58:24 AM